Toni L Pitcher
Overview
Explore the profile of Toni L Pitcher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Heron C, Horne K, MacAskill M, Livingston L, Melzer T, Myall D, et al.
Neurology
. 2025 Feb;
104(5):e209958.
PMID: 39961076
No abstract available.
2.
Laansma M, Zhao Y, van Heese E, Bright J, Owens-Walton C, Al-Bachari S, et al.
NPJ Parkinsons Dis
. 2024 Nov;
10(1):223.
PMID: 39557903
Alterations in subcortical brain regions are linked to motor and non-motor symptoms in Parkinson's disease (PD). However, associations between clinical expression and regional morphological abnormalities of the basal ganglia, thalamus,...
3.
MacAskill M, Pitcher T, Melzer T, Myall D, Horne K, Shoorangiz R, et al.
J R Soc N Z
. 2024 Oct;
53(4):466-488.
PMID: 39439968
We describe the New Zealand Parkinson's Progression Programme (NZP3), its goals, findings, and future plans. To date, 354 people with Parkinson's disease and 89 healthy older controls have participated over...
4.
Owens-Walton C, Nir T, Al-Bachari S, Ambrogi S, Anderson T, Aventurato I, et al.
NPJ Parkinsons Dis
. 2024 Aug;
10(1):151.
PMID: 39128907
The progression of Parkinson's disease (PD) is associated with microstructural alterations in neural pathways, contributing to both motor and cognitive decline. However, conflicting findings have emerged due to the use...
5.
Aye W, Stark M, Horne K, Livingston L, Grenfell S, Myall D, et al.
Alzheimers Dement (Amst)
. 2024 Jun;
16(2):e12601.
PMID: 38912306
Introduction: Recent work suggests that amyloid beta (Aβ) positron emission tomography (PET) tracer uptake shortly after injection ("early phase") reflects brain metabolism and perfusion. We assessed this modality in a...
6.
Kerestes R, Laansma M, Owens-Walton C, Perry A, van Heese E, Al-Bachari S, et al.
Mov Disord
. 2023 Nov;
38(12):2269-2281.
PMID: 37964373
Background: Increasing evidence points to a pathophysiological role for the cerebellum in Parkinson's disease (PD). However, regional cerebellar changes associated with motor and non-motor functioning remain to be elucidated. Objective:...
7.
Laansma M, Bright J, Al-Bachari S, Anderson T, Ard T, Assogna F, et al.
Mov Disord
. 2021 Jul;
36(11):2583-2594.
PMID: 34288137
Background: Brain structure abnormalities throughout the course of Parkinson's disease have yet to be fully elucidated. Objective: Using a multicenter approach and harmonized analysis methods, we aimed to shed light...
8.
Blakemore R, Pascoe M, Horne K, Livingston L, Young B, Elias B, et al.
N Z Med J
. 2021 Jul;
134(1538):44-51.
PMID: 34239144
Aims: Stress plays a key role in Parkinson's disease (PD) by acting on the dopaminergic system and worsening patients' motor function. The impact of New Zealand's strict lockdown measures to...
9.
Horne K, MacAskill M, Myall D, Livingston L, Grenfell S, Pascoe M, et al.
Mov Disord Clin Pract
. 2021 Apr;
8(3):390-399.
PMID: 33816668
Background: Neuropsychiatric symptoms in Parkinson's disease (PD) may increase dementia (PDD) risk. The predictive value of these symptoms, however, has not been compared to clinical and demographic predictors of future...
10.
Nabais M, Laws S, Lin T, Vallerga C, Armstrong N, Blair I, et al.
Genome Biol
. 2021 Mar;
22(1):90.
PMID: 33771206
Background: People with neurodegenerative disorders show diverse clinical syndromes, genetic heterogeneity, and distinct brain pathological changes, but studies report overlap between these features. DNA methylation (DNAm) provides a way to...